New triple attack on tough liver cancer shows promise
Disease control
Completed
This study tested a new three-part treatment for advanced bile duct cancer that cannot be removed by surgery. It combined a targeted chemotherapy delivered directly to the liver, a drug that blocks cancer growth signals, and an immunotherapy drug. The goal was to see if this comb…
Phase: PHASE2 • Sponsor: Zhongda Hospital • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC